Intratumoral Injection of Dendritic Cells Transduced by an SV40-Based Vector Expressing Interleukin-15 Induces Curative Immunity Mediated by CD8+ T Lymphocytes and NK Cells
Open Access
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (5) , 950-959
- https://doi.org/10.1016/j.ymthe.2005.03.030
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients With Metastatic Gastrointestinal CarcinomasJournal of Clinical Oncology, 2005
- Factors Influencing the Production of Recombinant SV40 VectorsMolecular Therapy, 2004
- Simian Virus-40 as a Gene Therapy VectorDNA and Cell Biology, 2004
- Dendritic cell‐derived IL‐15 controls the induction of CD8 T cell immune responsesEuropean Journal of Immunology, 2003
- IFN-γ-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic miceEuropean Journal of Immunology, 2002
- Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12Gene Therapy, 2001
- Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12Cancer Gene Therapy, 1999
- Gene Delivery to the Liver Using Simian Virus 40-derived VectorsSeminars in Liver Disease, 1999
- In vivo cytotoxic T-lymphocyte induction may take place via CD8+ T helper lymphocytesResearch in Immunology, 1995
- Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 ReceptorScience, 1994